| Bid Price | 6.60p | High Price | 6.60p |
|---|
| Ask Price | 6.80p | Low Price | 4.10p |
|---|
| Open Price | 4.20p | Spread | 2.94% |
|---|
| Prev Close | 4.20p | Volume | 10,721,267 |
|---|
Fusion Antibodies PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 3, 2024 | 4.20 | 4.30 | 4.26 | 4.20 | 75,345 |
| Dec 2, 2024 | 4.25 | 4.30 | 4.10 | 4.20 | 96,441 |
| Nov 29, 2024 | 4.30 | 4.34 | 4.20 | 4.25 | 119,235 |
| Nov 28, 2024 | 4.30 | 4.37 | 4.20 | 4.30 | 20,316 |
| Nov 27, 2024 | 4.30 | 4.40 | 4.20 | 4.30 | 47,565 |
Fusion Antibodies PLC Information
| Name | Fusion Antibodies PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDQZGK16 | Epic | FAB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 95.95 m | Prev Close | 4.20p |
|---|
| PE Ratio | | Market Cap | £6.33 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.519244 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.252273 | Quick Ratio | 2.729545 |
|---|
Fusion Antibodies PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 22/10/24 | LOF | Colin Walsh | NED | 325,301 @ £0.04 | £13,500.00 |
| 22/10/24 | LOF | Simon Douglas | CH | 180,722 @ £0.04 | £7,500.00 |
| 22/10/24 | LOF | Matthew Baker | NED | 81,325 @ £0.04 | £3,375.00 |
| 16/10/24 | BUY | Adrian Kinkaid | CEO | 83,728 @ £0.04 | £3,504.00 |
| 09/09/24 | BUY | Richard Buick | ED | 94,825 @ £0.03 | £3,106.00 |
| 05/09/24 | BUY | Adrian Kinkaid | CEO | 120,000 @ £0.03 | £3,804.00 |
| 22/07/24 | BUY | Simon Douglas | CH | 150,000 @ £0.03 | £4,815.00 |
| 04/12/23 | BUY | Simon Douglas | CH | 100,565 @ £0.05 | £4,988.00 |
| 04/12/23 | BUY | Adrian Kinkaid | CEO | 101,847 @ £0.05 | £4,991.00 |
| 12/06/23 | BUY | Richard Buick | ED | 68,750 @ £0.07 | £4,950.00 |
Fusion Antibodies PLC News
